SEC Form 4 · accession 0002018686-26-000014
Black Diamond Therapeutics, Inc. · BDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Prakash Raman
Director
Period of report
Sep 18, 2026
Accepted (ET)
Sep 21, 2026 · 5:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001701541
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 18, 2026 | A | 6,801 | $1.93 | A | 51,840 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were issued in accordance with the Issuer's Sixth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- F2The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 17, 2026.